Janssen - Be part of something great
Janssen is an international pharmaceutical company belonging to the Johnson & Johnson Group and is engaged in the development of breakthrough drugs in the medical world. Guided by Johnson & Johnson’s Credo and values and with commitment to quality of life being at the forefront of its priorities, Janssen devotes considerable resources to developing drugs for the treatment of serious and life-threatening illnesses, as well as medicines that improve the quality of patients' lives.
Janssen Global development centre develops drugs for a wide range of medical fields.
In recent years, it has focused on three main therapeutic areas:
Oncology and Hemato-oncology - drugs to extend life expectancy and improve patients’ quality of life.
Autoimmune Diseases - drugs for the treatment of inflammatory bowel disease (ulcerative colitis and Crohn's), arthritis and psoriasis, and for enhancing the quality of life of sufferers of these diseases.
Psychiatry - drugs focusing on the treatment of schizophrenia and chronic depression aimed at significantly improving patients’ quality of life.
In June 2017, Janssen Global acquired the Swiss company Actelion, a leader in the field of pulmonary hypertension (PH), and pulmonary arterial hypertension (PAH). Marketed today through Janssen, these drugs facilitate various stages of pulmonary disease.
Janssen Israel is responsible for the marketing and sales of all Janssen drugs in Israel, including importing them, the registration process in the Ministry of Health, and their inclusion in the healthcare basket.
The company is actively engaged in increasing awareness of various diseases and their therapeutic pathways, conducting educational and training activities for medical teams, and collaborating with various patient associations.
Whether serving as medical reps, product managers, team managers or medical consultants, Janssen Israel employees have highly rewarding collaborative relationships with medical staff and other health care professionals, and this contributes immensely to the sense of purpose, responsibility and involvement experienced by those who work at our company.
Work at Janssen combines professional challenges, pursuit of excellence, and a unique opportunity to be at the forefront of pharmacology, bringing the promise of enhanced quality of life to thousands of patients in Israel
Working alongside our drug development activities, the GCO (Global Clinical Operation) Group is responsible for conducting clinical research and development for assessing the efficacy and safety of all drugs manufactured by Janssen.
The GCO group supports clinical studies in over 40 countries worldwide, enabling evaluation among a diverse range of populations. In Israel, the group's studies are conducted in most of the country’s hospitals.
At Janssen, professional excellence and meeting tough professional challenges go hand in hand with our sense of mission and purpose. Our employees welcome the unique opportunity of working at the forefront of modern pharmacology and enabling a higher quality of life to thousands of patients in Israel.
Janssen selects its employees carefully and sets the bar high for entry, with regard to professional and personal skills. Employees at Janssen Israel are predominantly graduates in Life Sciences, Pharmacology and Medicine, and are proud to belong to a company whose products have added value and enhance patients’ quality of life. Janssen Israel places great importance on helping its employees to develop professionally and on promoting them. Through training programs, professional workshops, utilization of the latest technologies, cross-cultural collaboration with colleagues from other Janssen divisions worldwide, and exposure to exciting challenges in the medical field, our employees are able to fulfil their potential, realize their skills and talents, and advance to new heights.